These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 10433563

  • 1. Human immunodeficiency virus infection, anemia, and survival.
    Moore RD.
    Clin Infect Dis; 1999 Jul; 29(1):44-9. PubMed ID: 10433563
    [Abstract] [Full Text] [Related]

  • 2. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP, Abels RI, McNeill MV, Sullivan DJ.
    Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
    Henry DH, Brooks BJ, Case DC, Fishkin E, Jacobson R, Keller AM, Kugler J, Moore J, Silver RT, Storniolo AM, Abels RI, Gordon DS, Nelson R, Larholt K, Bryant E, Rudnick S.
    Cancer J Sci Am; 1995 Dec 13; 1(4):252-60. PubMed ID: 9166485
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anemia and its treatment and outcomes in persons infected with human immunodeficiency virus.
    Buskin SE, Sullivan PS.
    Transfusion; 2004 Jun 13; 44(6):826-32. PubMed ID: 15157246
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer.
    Henry DH.
    Semin Hematol; 1993 Oct 13; 30(4 Suppl 6):12-6. PubMed ID: 8153671
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ, Gottlieb MS.
    Ann Intern Med; 1992 Nov 01; 117(9):739-48. PubMed ID: 1416576
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of recombinant human erythropoietin versus transfusions in the treatment of zidovudine-related anemia in HIV-infected children.
    Allen UD, Kirby MA, Goeree R.
    Pediatr AIDS HIV Infect; 1997 Feb 01; 8(1):4-11. PubMed ID: 11361510
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M.
    Haematologica; 2001 Jan 01; 86(1):44-51. PubMed ID: 11146570
    [Abstract] [Full Text] [Related]

  • 18. Biology of anemia, differential diagnosis, and treatment options in human immunodeficiency virus infection.
    Claster S.
    J Infect Dis; 2002 May 15; 185 Suppl 2():S105-9. PubMed ID: 12001030
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.